(Q83025404)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094818%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Can metronidazole still be used for treatment of Clostridium difficile infections? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094818%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Clostridium difficile

object named as

Clostridium difficile

1 reference

Haihui Huang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094818%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Carl Erik Nord

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094818%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094818%20AND%20SRC:MED&resulttype=core&format=json

Current infectious disease reports

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094818%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094818%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094818%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

3-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094818%20AND%20SRC:MED&resulttype=core&format=json

Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin

18 January 2020

cites work

1 reference

12 December 2020

Risk factors for recurrence of Clostridium difficile-associated diarrhea in the elderly

1 reference

12 December 2020

Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin

1 reference

12 December 2020

Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

1 reference

12 December 2020

Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide

1 reference

12 December 2020

Prevalence of nim genes in anaerobic/facultative anaerobic bacteria isolated in South Africa

1 reference

12 December 2020

Metronidazole resistance in Bacteroides spp. carrying nim genes and the selection of slow-growing metronidazole-resistant mutants

1 reference

12 December 2020

High levels of resistance to fluoroquinolones among Clostridium difficile isolates in a Spanish hospital

1 reference

12 December 2020

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults

1 reference

12 December 2020

Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest.

1 reference

12 December 2020

Metronidazole is still the drug of choice for treatment of anaerobic infections

1 reference

12 December 2020

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis

1 reference

12 December 2020

Structural basis of 5-nitroimidazole antibiotic resistance: the crystal structure of NimA from Deinococcus radiodurans.

1 reference

12 December 2020

Emergence of reduced susceptibility to metronidazole in Clostridium difficile

1 reference

12 December 2020

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

1 reference

12 December 2020

Clostridium difficile colitis: factors influencing treatment failure and relapse--a prospective evaluation.

1 reference

12 December 2020

Treatment of Clostridium difficile infection.

1 reference

12 December 2020

Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada

1 reference

12 December 2020

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

1 reference

12 December 2020

Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital

1 reference

12 December 2020

Clostridium difficile--more difficult than ever

1 reference

12 December 2020

An epidemic, toxin gene-variant strain of Clostridium difficile

1 reference

12 December 2020

Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea

1 reference

12 December 2020

Comparison of the E test to the reference agar dilution method for antibiotic susceptibility testing of Clostridium difficile

1 reference

12 December 2020

Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.

1 reference

12 December 2020

Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile

1 reference

12 December 2020

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

1 reference

12 December 2020

Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract

1 reference

12 December 2020

The protective effect of vancomycin on clindamycin-induced colitis in hamsters

1 reference

12 December 2020

Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system

1 reference

12 December 2020

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea

1 reference

12 December 2020

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

1 reference

12 December 2020

Reduced susceptibility of Clostridium difficile to metronidazole.

1 reference

12 December 2020

Metronidazole resistance in Clostridium difficile is heterogeneous

1 reference

12 December 2020

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea

1 reference

12 December 2020

Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease

1 reference

12 December 2020

Clostridium difficile-associated diarrhoea: bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses

1 reference

12 December 2020

Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.

1 reference

12 December 2020

10.1007/S11908-009-0001-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19094818%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference